Trial intelligence / Profile preview

Quyu Zhixue Granules for Ovulatory Dysfunction Abnormal Uterine Bleeding

CTR20190483Phase 2Active

Sponsor
Beijing Shengshi Liangfang Pharmaceutical Technology
Start
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Quyu Zhixue Granules in menstrual disorders, hypermenorrhea, sponsored by Beijing Shengshi Liangfang Pharmaceutical Technology. Started Aug 2019; status: active.

02

Drugs

Quyu Zhixue Granules
03

Conditions

menstrual disordershypermenorrhea

Beyond the preview

Go deeper on CTR20190483.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20190483.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call